Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years-Reference-Cited by-同舟云学术

Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years

Published:2022-05 Issue: Volume:61 Page:103777
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Ghadiri Fereshteh,Sahraian Mohammad Ali,Baghbanian Seyed Mohammad,Ashtari Fereshteh,Razazian Nazanin,Majdinasab Nastaran,Poursadeghfard Maryam,Hatamian Hamidreza,Harirchian Mohammad Hossein,Beladimoghadam Nahid,Azimi Amirreza,Sharifipour Ehsan,Hosseini Samaneh,Bayati Asghar,Kamali Hoda,Hosseni Nejad Mir Nahid,Faraji Fardin,Mozhdehipanah Hossein,Modara Farhad,Navardi Samira,Heidari Hora,Ayoubi Saeideh,Naser Moghadasi Abdorreza^ORCID,Eskandarieh Sharareh

Funder

Tehran University of Medical Sciences and Health Services

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference27 articles.

1. Use of disease-modifying therapies in pediatric relapsing-remitting multiple sclerosis in the United Kingdom;Abdel-Mannan;Neurol. Neuroimmunol. Neuroinflamm.,2021

2. Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis;Amato;Brain,2020

3. Late-onset multiple sclerosis is associated with an increased rate of reaching disability milestones (760);Andersen;Neurology,2020

4. Epidemiology of multiple sclerosis in Iran: a systematic review and meta-analysis;Azami;PLoS One,2019

5. Sclerose des cordons lateraux de la moelle epinere chez femmehysterique atteinte de contracture peranemte des quatre membres;Charcot;Bull. Soc. Med. Hop. Paris,1965

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The disease-modifying therapy utilisation and cost trend for multiple sclerosis in Australia between 2013 and 2022;Multiple Sclerosis Journal;2023-11-24

2. Epidemiological parameters of multiple sclerosis in Chaharmahal and Bakhtiari Province, Iran;Current Journal of Neurology;2023-08-08

3. Drug Recommender System Based on Collaborative Filtering for Multiple Sclerosis Patients;2023 9th International Conference on Web Research (ICWR);2023-05-03

4. The National Multiple Sclerosis Registry System of Iran (NMSRI): aspects and methodological dimensions;Multiple Sclerosis and Related Disorders;2023-04

5. Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics;Multiple Sclerosis and Related Disorders;2023-02